ARCHIVES

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

NCI Community Intervention Trial Reports

March 10, 1995

Decision On Status Of Frederickson, DeVita Due In Month, Schweiker Says

May 1, 1981

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992